FDA Regulation of Over-the-Counter (OTC) Drugs

Both new and experiences OTC manufacturers will benefit from a review of the various FDA rules for OTC drugs. Knowledge of these rules and regulations is important for staying out of trouble with the FDA, which should be one of the main objectives of every drug manufacturer.

Definitions of prescription (Rx) and OTC drugs will be presented. The three ways that FDA regulates OTC drugs, Monographs, Applications and Rx to OTC switches, will be discussed. Labeling rules for OTC products will be reviewed. Other requirements, including Registration, Drug Listing and Current Good Manufacturing Practice, will be covered. Examples from recent Warning Letters and FDA Inspectional Observations (483s) will be used to show what not to do.

Areas Covered in the Session :

  • Rx versus OTC
  • How are OTC drugs regulated?
  • Monographs
  • NDA or ANDA
  • Rx to OTC Switch
  • Labeling
  • GMPs
Who Should Attend:

  • Quality Departments
  • Regulatory Affairs Departments
  • Marketing Departments
  • Labeling Experts


Dr. Loren Gelber

Dr. Loren Gelber has more than 40 years of experience in pharmaceutical industry regulatory compliance. She worked for about 10 years at the FDA, including as a reviewer in the Division of Generic Drugs. She then transitioned to industry, working for four different pharmaceutical companies. For the last 13 years she has been a regulatory compliance consultant, both for consulting companies and independently.

  Go PRIME   🛈 $ 240 SELECT
  Personal Plan 🛈 $ 3000 SELECT
  Business Plan 🛈 $ 9000 SELECT

  • Login Information with Password to join the session, 24 hours prior to the webinar
  • Presentation Handout in .pdf format
  • Presentation from the Speaker
  • Feedback form
  • Certificate of Attendance
  • Recording access Information with Password to view the webinar, will be sent 24 hours after the completion of the Live webinar.
  • Presentation Handout in .pdf format
  • Certificate of Attendance